CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study evaluates ATI-045 versus placebo in patients with Moderate-to-Severe Atopic Dermatitis.
Phase 2
Cary, North Carolina, United States and 60 other locations
Clinical trials
Research sites
Resources
Legal